Multipotent Neural Stem Cells from the Adult Tegmentum with Dopaminergic Potential Develop Essential Properties of FunctionalNeurons by 源��룞�슧
Multipotent Neural Stem Cells from the Adult Tegmentum with
Dopaminergic Potential Develop Essential Properties of
Functional Neurons
ANDREAS HERMANN,a,b,c MARTINA MAISEL,a,c FLORIAN WEGNER,d STEFAN LIEBAU,a,e DONG-WOOK KIM,b
MANFRED GERLACH,f JOHANNES SCHWARZ,d,g KWANG-SOO KIM,b ALEXANDER STORCHc
aDepartment of Neurology, University of Ulm, Ulm, Germany; bMolecular Neurobiology Laboratories; McLean
Hospital/Harvard Medical School, Belmont, Massachusetts, USA; cDepartment of Neurology, Technical University
of Dresden, Dresden, Germany; dDepartment of Neurology, University of Leipzig, Leipzig, Germany; eDepartment
of Anatomy and Cell Biology, University of Ulm, Ulm, Germany; fClinical Neurochemistry, Department of Child
and Youth Psychiatry and Psychotherapy, University of Wu¨rzburg, Wu¨rzburg, Germany; gDivision of Biology,
California Institute of Technology, Pasadena, California, USA
Key Words. Adult neurogenesis • Neural stem cells • Dopaminergic differentiation • Parkinson’s disease • Electrophysiology
Neuroregeneration
ABSTRACT
Neurogenesis in the adult brain occurs within the two
principal neurogenic regions: the hippocampus and the
subventricular zone of the lateral ventricles. The occur-
rence of adult neurogenesis in non-neurogenic regions,
including the midbrain, remains controversial, but isola-
tion of neural stem cells (NSCs) from several parts of the
adult brain, including the substantia nigra, has been re-
ported. Nevertheless, it is unclear whether adult NSCs do
have the capacity to produce functional dopaminergic
neurons, the cell type lost in Parkinson’s disease. Here, we
describe the isolation, expansion, and in vitro character-
ization of adult mouse tegmental NSCs (tNSCs) and their
differentiation into functional nerve cells, including do-
paminergic neurons. These tNSCs showed neurosphere
formation and expressed high levels of early neuroecto-
dermal markers, such as the proneural genes NeuroD1,
Neurog2, and Olig2, the NSC markers Nestin and
Musashi1, and the proliferation markers Ki67 and BrdU
(5-bromo-2-deoxyuridine). The cells showed typical pro-
pidium iodide–fluorescence-activated cell sorting analysis
of slowly dividing cells. In the presence of selected growth
factors, tNSCs differentiated into astroglia, oligodendro-
glia, and neurons expressing markers for cholinergic,
GABAergic, and glutamatergic cells. Electrophysiological
analyses revealed functional properties of mature nerve
cells, such as tetrodotoxin-sensitive sodium channels, ac-
tion potentials, as well as currents induced by GABA
(-aminobutyric acid), glutamate, and NMDA (N-methyl-
d-aspartate). Clonal analysis demonstrated that individ-
ual NSCs retain the capacity to generate both glia and
neurons. After a multistep differentiation protocol using
co-culture conditions with PA6 stromal cells, a small
number of cells acquired morphological and functional
properties of dopaminergic neurons in culture. Here, we
demonstrate the existence of adult tNSCs with functional
neurogenic and dopaminergic potential, a prerequisite for
future endogenous cell replacement strategies in Parkin-
son’s disease. STEM CELLS 2006;24:949–964
INTRODUCTION
Neurogenesis in the adult mammalian brain is a generally ac-
cepted phenomenon in two discrete neurogenic regions: the
hippocampus and the subventricular zone (SVZ) of the lateral
ventricles [1–5]. In recent years, neurogenesis was reported to
occur in other regions of the adult brain under normal condi-
tions, such as the neocortex [2], amygdala [6], and substantia
nigra [7]. Moreover, various brain insults have been shown to
induce the production of new neurons in the striatum [8], cortex
[9, 10], and substantia nigra [7]. However, other research groups
were not able to replicate some of these reports [11, 12], and
some have been challenged on methodological grounds [11–15].
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For example, a recent study by Frielingsdorf and colleagues [13]
could not reproduce the data reported by Zhao and coworkers
[7] showing adult dopaminergic neurogenesis in the substantia
nigra, including re-establishment of the nigro-striatal dopami-
nergic connections. They did not find newly generated dopami-
nergic neurons by the 5-bromo-2-deoxyuridine (BrdU) incorpo-
ration assay in normal or 6-hydroxydopamine–lesioned animals.
They further argued that in vivo labeling of new neurons in the
substantia nigra with DiI might be related to retrograde labeling
of existing nigral neurons [13]. These data are in line with
earlier studies showing that adult substantia nigra progenitor
cells give rise to glial cells only [16]. However, the in vivo
differentiation pattern may not reflect the entire lineage poten-
tial of resident progenitor cells, because regional environmental
factors appear to restrict in situ differentiation to distinct neural
lineages. For example, in vitro analysis and transplantation
studies have suggested that progenitor cells from the adult
substantia nigra, similar to progenitors from the adult spinal
cord, have the potential to give rise to cells of all neural lineages
[16–18]. In addition, isolated cortical progenitor cells have the
potential to give rise to glia and neurons in vitro [19].
Clonogenic neural stem cells (NSCs) are self-renewing cells
that maintain the capacity to differentiate into brain-specific cell
types and may also replace or repair diseased brain tissue.
Multipotent NSCs with the potential to generate mature cells of
all neural lineages, including astroglia, oligodendroglia, and
neurons, have been consistently demonstrated within the hip-
pocampus and the SVZ of lateral ventricles [20–26]. These cells
grow in vitro as spherical floating clusters (neurospheres) in the
presence of epidermal growth factor (EGF) [21, 27]. Previous
work has reported that SVZ NSCs correspond to a rare popu-
lation of relatively quiescent cells. More recently, it has been
suggested that not the ciliated ependymal cells correspond to the
NSCs [24] but that SVZ astrocytes act as NSCs in both the
normal and regenerating adult brain [28]. Recent studies dem-
onstrated the presence of multipotent central nervous system
(CNS) stem cells in non-neurogenic regions of the adult brain,
including the spinal cord and the ventricular neuraxis [17, 18].
In contrast to SVZ NSCs, the proliferation of these NSCs
depends on both EGF and fibroblast growth factor-2 (FGF-2)
[18, 26]. Lie and coworkers described the isolation of multipo-
tent NSCs from the adult substantia nigra with neurogenic
differentiation capacity in vitro and after transplantation into the
adult hippocampus [16]. However, the authors neither reported
on detailed characterization of these progenitor cells in vitro nor
provided data on neuronal subtype specification or functional
properties after differentiation. Moreover, similar to all other
adult CNS stem cells, these midbrain-derived NSCs did not
differentiate into dopaminergic nerve cells [16].
Here, we show the presence of multipotent clonogenic NSCs
in the adult mouse tegmentum (tegmental NSCs [tNSCs]) with
all major properties of CNS stem cells such as neurosphere
formation, expression of Nestin and other NSC markers, as well
as significant telomerase activity. They show the capacity to
differentiate in vitro into all neural cell lineages, including
astroglia, oligodendroglia, and neurons. Moreover, the resulting
nerve cells displayed morphological and functional properties of
mature neuronal subpopulations, such as GABAergic and dopa-
minergic neurons.
MATERIALS AND METHODS
Sphere Culture
Adult mice (6–10-week-old male C57BL/6 mice) were killed by
cervical dislocation, and their brains were removed and placed
into ice-cold Hanks’ balanced saline solution supplemented with
1% penicillin/streptomycin and 1% glucose (all from Gibco,
Tulsa, OK, http://www.invitrogen.com). The tegmental tissue
(midbrain and hindbrain), including the subependymal zone/
SVZ of the aqueduct and fourth ventricle, was then aseptically
prepared using a dissection microscope. The meninges were
carefully removed from the tissue after preparation of the teg-
mental area. For comparative studies with NSCs from adult’s
principal neurogenic regions, we isolated the hippocampus from
the same mice as described previously [19]. For expansion of
neurospheres, tissue samples from both regions were incubated
in 0.1% trypsin (Sigma, St. Louis, http://www.sigmaaldrich.
com) for 10 minutes at room temperature, incubated in DNase
(40 mg/ml; Sigma) for 10 minutes at 37°C, and homogenized to
a quasi–single-cell suspension by gentle triturating [29]. The
cells were added to 25-cm2 flasks (2–3  106 viable cells per
flask) in serum-free Neurobasal (NBa) medium containing 1%
glutamate, 2% B27 supplement, and 1% penicillin/streptomycin
(all from Gibco) supplemented with 20 ng ml1 of both mito-
gens FGF-2 and EGF (both from Sigma). After 10–20 days,
sphere formation was observed. These neurospheres were ex-
panded for an additional 3–12 weeks (in total, five to 10 pas-
sages) before terminal differentiation was initiated. The medium
was changed once a week, and growth factors were added twice
a week. For BrdU labeling, cells were incubated for 30 hours
with 10 M BrdU.
Differentiation Conditions
Induction of neural differentiation (protocol 1) was initiated by
plating the cells on poly-L-lysine (PLL)-coated glass coverslips
at a concentration of 1.5–2.0  105 cells cm2 in NBa medium
containing 1% glutamate, 2% B27 supplement, and 1% penicil-
lin/streptomycin supplemented with 0.5 mol l1 all-trans-
retinoic acid (Sigma), 10 ng ml1 brain-derived neurotrophic
factor (BDNF; Promega, Madison, WI, http://www.promega.
com), and 100 M dibuteryl(db)-cAMP (Sigma). Cells were
differentiated for 14 days. For analyzing the differentiation
capacity of tNSCs, several other combinations of growth fac-
tors/cytokines were used (Table 1). The following substances
were used: 10% fetal bovine serum (Biochrom AG, Berlin,
http://www.biochrom.de), 100 pg/ml interleukin (IL)-1b, 1
ng/ml IL-11, 10 ng/ml glial cell line–derived neurotrophic fac-
tor, 1 ng/ml leukemia inhibitory factor (all from Sigma), 10
ng/ml FGF-4, 10 ng/ml FGF-8, and 10 ng/ml sonic hedgehog
(Shh; all from R&D Systems, Minneapolis, http://www.
rndsystems.com). For co-culture analyses, various feeder cells
(mouse embryonic fibroblasts [MEFs]), PA6 stromal cells, as
well as cortical and striatal astrocytes from embryonic day 14.5
[E14.5] rat embryos) were cultured on gelatine-coated cover
slides as described earlier [29, 30]. Before plating the tNSCs on
the feeder layers, the cells were incubated with expansion media
supplemented with 500 ng/ml Shh and 100 ng/ml FGF-8 for 48
hours (“pre-stimulation”). When co-culture was started, conflu-
ent feeder cells where washed twice with phosphate-buffered
saline (PBS) and tNSCs were seeded at a concentration of
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1.5–2.0  105 cells cm2 in Glasgow’s modified Eagle’s
medium (Gibco) containing 1% glutamine, 1 mM sodium
pyruvate, 0.1 mM nonessential amino acids, and 0.1 mM
2-mercaptoethanol (“differentiation medium” [DM]) supple-
mented with 10% knockout-serum replacement (Gibco). Me-
dium change was performed on day 4 and every other day
after that. After 7 days, the medium was changed to “differ-
entiation medium” supplemented with 1% N2 (DM-N2 me-
dium; Gibco).
Clonal Analysis
Clonal analysis was performed according to Uchida and co-
workers [31]. In brief, tNSCs were serially diluted into expan-
sion medium in 96-multiwell plates. On the next day, single
cell–containing wells (assessed microscopically) were ex-
panded by supplementing the medium to 50% with conditioned
medium containing growth factors. Cells were expanded for
3–6 weeks and then differentiated using feeder cell–free differ-
entiation protocol 1.
Flow Cytometry
tNSCs were treated with Accumax (Gibco) and washed with
PBS. Dead cells were excluded from analysis by forward-scatter
gating. Samples were processed using a FACSCalibur flow
cytometer, and analyses were performed with the Cellquest
software (both from Becton, Dickinson and Company, Frank-
lin Lakes, NJ, http://www.bd.com). Antibodies were used as
follows: CD34–fluorescein isothiocyanate (FITC) 1:10,
CD45-phycoerythrin (PE) 1:10, CD24-FITC 1:200 (all from
Chemicon, Temecula, CA, http://www.chemicon.com), rat
anti-prominin1 monoclonal antibody 13A4 1:300 (BD Bio-
sciences, San Diego, http://www.bdbiosciences.com), and
mSSEA1 1:5 (kindly provided by Dr. Beltinger, University of
Ulm) followed by fluorescence-labeled secondary antibodies
(Jackson ImmunoResearch Laboratories, West Grove, PA,
http://www.jacksonimmuno.com). Propidium iodide (PI)–
fluorescence-activated cell sorting (FACS) was performed as
previously described [32]. In brief, the cells were dissociated
by trypsin (Gibco) and washed with PBS. The cells were
fixed with 80% ice-cold ethanol and incubated at 20°C for
30 minutes. The cells were washed with PBS and PI-stained
(0.5 mg/ml PI in 0.038 M sodium citrate buffer [pH 7.0]) for
30 minutes in the dark (37°C). Dead cells were excluded from
analysis by forward-scatter gating. A minimum of 10,000–
12,000 events were acquired for each sample.
Table 1. Differentiation capacity of adult tegmental neural stem cells
Differentiation conditions (growth
factors/cytokines/co-cultures)
MAP2ab or Tuj1
neurons
GFAP
astrocytes
GalC oligoden-
drocytes
TH
neurons
BDNF on PLL    
dbcAMP on PLL    
Retinoic acid on PLL    
BDNF, retinoic acid on PLL    
BDNF, dbcAMP, retinoic acid on PLL
(protocol 1)
   
FBS on PLL    
IL-1b on PLL    
IL-1b, IL-11, GDNF, LIF on PLL    
FGF-4, Shh on PLL    
FGF-8, Shh on PLL    
dbcAMP, FGF-8, Shh on PLL    
Pre-stimulation (FGF-8) on PLL  n.d. n.d. 
Pre-stimulation (FGF-8)  CM on PLL  n.d. n.d. 
Pre-stimulation (Shh) on PLL  n.d. n.d. 
Pre-stimulation (Shh)  CM on PLL  n.d. n.d. 
Pre-stimulation (FGF-8  Shh) on PLL
(protocol 2)
  n.d. 
Pre-stimulation (FGF-8  Shh)  CM on
PLL
  n.d. 
Pre-stimulation (FGF-8  Shh) on MEFs
(protocol 3)
   
Pre-stimulation (FGF-8  Shh) on
cortical astrocytes
 n.d. n.d. 
Pre-stimulation (FGF-8  Shh) on striatal
astrocytes
 n.d. n.d. 
Pre-stimulation (FGF-8  Shh) on PA6
cells (protocol 4)
   
Immunostainings were scored as  if no cells were positive for the respective marker,  if up to 5% of cells were positive,  if 5%–
25% of cells were positive,  if 25%–75% of cells were positive, and  if more than 75% of cells were positive.
Abbreviations: BDNF, brain-derived neurotrophic factor; CM, conditioned medium on PA6 cells; dbcAMP, dibuteryl-cAMP; FBS, fetal
bovine serum; FGF, fibroblast growth factor; GalC, galactocerebrosidase C; GDNF, glial cell line–derived neurotrophic factor; GFAP,
glial fibrillary acidic proetin; IL, interleukin; LIF, leukemia inhibitory factor; MAP2ab, monoclonal antimicrotubule-associated protein
2ab; MEF, mouse embryonic fibroblast; n.d., not determined; PLL, poly-L-lysine; Shh, sonic hedgehog; TH, tyrosine hydroxylase.
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Immunocytochemistry
Cell cultures were fixed in 4% paraformaldehyde in PBS or with
4% paraformaldehyde/PBS followed by ice-cold acidic ethanol
and HCl for BrdU staining. Immunocytochemistry was carried
out using standard protocols. Cell nuclei were counterstained
with 4,6-diamidino-2-phenylindole (DAPI). The following pri-
mary antibodies were used: mouse anti-Tuj1 1:500 or rabbit
anti-Tuj1 1:2,000 (Covance, Richmond, CA, http://www.
covance.com), sheep or rabbit anti–tyrosine hydroxylase (TH)
1:200 (Pel-Freez, Rogers, AR, http://www.pel-freez.com), rab-
bit anti-serotonin (5-HT) 1:2,500 (DiaSorin, Stillwater, MN,
http://www.diasorin.com), rabbit anti-cholineacetyltransferase
1:500, mouse anti-galactocerebrosidase C (GalC) 1:750, rabbit
anti–glial fibrillary acidic protein (GFAP) polyclonal 1:1,000,
mouse anti-Nestin monoclonal 1:500, anti-CD-24-FITC 1:200,
rabbit anti-neurogenin2 1:500, rabbit anti-neuroD1 1:500, rabbit
anti-Musashi1 1:500 (all from Chemicon), rabbit anti-Ki-67
1:500 (Novocastra Ltd., Newcastle upon Tyne, U.K., http://
www.novocastra.co.uk), rabbit anti–-aminobutyric acid
(GABA) 1:1,000, rabbit anti-glutamate 1:10,000 (both from
Sigma), mouse anti-GFAP monoclonal 1:1,000, mouse anti–
monoclonal antimicrotubule-associated protein 2ab (MAP2ab)
1:300 (all from BD Pharmingen, San Diego, http://www.
bdbiosciences.com/pharmingen), rat anti–prominin1-FITC
monoclonal antibody 13A4 1:800 (BD Biosciences), rat anti–
PSA-NCAM (polysialylated neural cell adhesion molecule)
1:250 (BD Pharmingen), rabbit anti-olig2 1:1,000 (kindly pro-
vided by Dr. Takebayashi; [33]) and fluorescence-labeled sec-
ondary antibodies (Jackson ImmunoResearch Laboratories), and
rat anti-BrdU 1:40 with fluorescence-labeled secondary anti-
body (both from Abcam, Cambridge, U.K., http://www.abcam.
com). Images were captured using a fluorescence microscope
(Axiovert 135; Zeiss, Oberkochen, Germany, http://www.zeiss.
com) or a Leica TCS/NT confocal microscope (Leica, Heer-
brugg, Switzerland, http://www.leica.com) equipped with kryp-
ton, krypton/argon, and helium lasers.
RNA Extraction and Quantitative Real-Time
RT-PCR Analysis
Total cellular RNA was extracted from tNSCs and 14-day
differentiated tNSCs (differentiation protocol 1) using RNAeasy
total RNA purification kit followed by treatment with RNase-
free DNase (Qiagen, Hilden, Germany, http://www.qiagen.
com). Quantitative real-time one-step reverse transcription–
polymerase chain reaction (RT-PCR) was carried out using the
LightCycler System (Roche, Mannheim, Germany, http://www.
roche.com), and amplification was monitored and analyzed by
measuring the binding of the fluorescence dye SYBR Green I to
double-stranded DNA. One microliter (50 ng) of total RNA was
reverse-transcribed and subsequently amplified using Quanti-
Tect SYBR Green RT-PCR Master mix (Qiagen) and 0.5 mol
l1 of both sense and antisense primers. Tenfold dilutions of
total RNA were used as external standards. Standards and sam-
ples were simultaneously amplified. After amplification, melt-
ing curves of the RT-PCR products were acquired to demon-
strate product specificity. The results are expressed relative to
the housekeeping gene HMBS (hydroxymethylbilane synthase).
Primer sequences, lengths of the amplified products, and melt-
ing point analyses are summarized in Table 2.
Telomerase Activity
A highly sensitive in vitro assay known as the quantitative
real-time telomeric repeat amplification protocol [34, 35] has
been used for detecting telomerase activity (OTD kit; Allied
Biotech, Inc., Ijamsville, MD, http://www.alliedbiotechinc.
com). The telomerase activity in the cell or tissue extract is
determined through its ability to synthesize telomeric repeats
onto an oligonucleotide substrate in vitro. Telomerase from cell
or tissue extracts adds telomeric repeats onto a substrate oligo-
nucleotide, and the resulting extended products are subsequently
amplified by the PCR. The PCR products are then visualized
using the DNA fluorochrome SYBR Green as described above.
Mouse embryonic stem cells (ESCs) (D3 ESC line) were used as
positive control and cultured as described previously [36], whereas
adult mouse cortical tissue was used as negative control [37].
Electrophysiology
Cells were investigated 7–20 days after differentiation using
standard whole-cell patch-clamp technique. Data were recorded
using an EPC-7 or EPC-9 amplifier (HEKA Electronics Inc.,
Lambrecht/Pfalz, Germany, http://www.heka.com) and pClamp
data acquisition software (Axon Instruments, Union City, CA,
http://www.moleculardevices.com) essentially as described pre-
viously [38, 39]. Extracellular solution contained (in mmol l1)
142 NaCl, 8.1 KCl, 1 CaCl2, 6 MgCl2, 10 HEPES, and 10
D-glucose (pH 7.4; 320 mOsm). Pipette solution contained (in
mmol l1) 153 KCl, 1 MgCl2, 5 EGTA, and 10 HEPES (pH 7.3;
305 mOsm). Using these solutions, borosilicate pipettes had
resistances of 6–10 M. Seal resistances in the whole-cell mode
were between 0.1 and 1 G. For recordings of GABA-induced
inward currents, the solutions were balanced giving an equilib-
rium potential of 0 mV for chloride ions. For recordings of
glutamate-induced inward currents, the external bath solution
contained (in mmol1) 162 NaCl, 1.2 CaCl2, 2.4 KCl, 0.01
glycine, 11 glucose, 10 HEPES (pH 7.3; 320 mOsm). Picrotoxin
(100 M; Sigma) and strychnine (2 M; Sigma) were added to
inhibit ligand-gated chloride channels. The internal solution
contained (in mmol1) 95 CsCl, 6 MgCl2, 1 CaCl2, 10 HEPES,
and 11 EGTA (pH 7.2; 300 mOsm). Drugs were applied rapidly
via gravity with an SF-77B perfusion fast-step system (Warner
Instruments LLC, Hamden, CT, http://www.warnerinstru-
ments.com). Data were analyzed using pClamp 8.0, Microsoft
Excel 97 (Microsoft, Redmond, WA, http://www.microsoft.
com), and Origin 5.0 software. Resting membrane potentials
(RMP) were determined immediately after gaining whole-cell
access. Action potentials (APs) were elicited by applying in-
creasing depolarizing current pulses (10-pA current steps). The
afterhyperpolarization (AHP) amplitude was measured from
peak to beginning of plateau reached during the current injec-
tion, AP duration was measured at half amplitude, and time to
peak AHP from spike onset.
Determination of Dopamine, GABA, and Serotonin
Production and Release
For determination of dopamine production and release, media
were supplemented with 100 mol l1 tetrahydrobiopterin and
200 mol l1 ascorbate 2 days prior to medium harvest. Dopa-
mine levels were determined in medium, and extracellular
buffer was stabilized with EGTA/glutathione solution as re-
ported previously [29] and stored at 80°C until analysis.
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Table 2. Primers for quantitative real-time reverse transcription–polymerase chain reaction
Gene (protein) Sequence (forward; reverse)
Product length
(bp)
Melting point
analysis
a
DDC 5-GTG GGT GAA GAG GAC TGA-3 182
(Dopa-decarboxylase) 5-GCA GCC CCT TGA CTC CGT A-3
DAT 5-ATG CTG CTC ACT CTG GGT ATC-3 135
(Dopamine transporter) 5-CAG GAA AGT AGC CAG GAC AAT-3
GFAP 5-GAT CTA TGA GGA GGA AGT TCG-3 183
(Glial fibrillary acidic protein) 5-TCT GCA AAC TTA GAC CGA TAC C-3
HMBS 5-TGT ATG CTG TGG GTC AGG GAG-3 144
(Hydroxymethylbilane
synthase)
5-CTC CTT CCA GGT GCC TCA GA-3
MBP 5-CAC GGG CAT CCT TGA CTC-3 130
(Myelin basic protein) 5-GCC GTG CTG CGA CTT C-3
MSI1 5-GCA GAC CAC GCA GGA AG-3 151
(Musashi 1) 5-CGC CAG CAC TTT ATC CAC-3
NeuroD1 5-CCG CCA CAC GCC TAC A-3 148
(Neurogenic differentiation 1) 5-CAA ACT CGG CGG ATG G-3
Neurog2 5-CGG CGT CAT CCT CCA AC-3 179
(Neurogenin 2) 5-CGG GTA GAG GAC GAG AGA GG-3
NES 5-TGG AAC AGA GAT TGG AAG GC-3 153
(Nestin) 5-TCT TGA AGG TGT GCC AGT TGC-3
NF 5-CAT CAG CAA GTC GGT AAA GG-3 133
(Neurofilament-160kd) 5-CTG CGG GCT ACG GTC A-3
Continued on following page
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Dopamine was assayed by reverse-phase high-performance liq-
uid chromatography (HPLC) with an electrochemical detector
as previously described [40]. GABA and serotonin were assayed
by HPLC with fluorescence detection [40], employing pre-
column derivatisation with ortho-phthaldialdehyde and an auto-
matic HPLC system (Kontron Instruments, Neufahrn, Ger-
many). The excitation and emission wave lengths of the
fluorescence detector were set at 330 and 450 nm, respectively.
Cell Counting and Statistics
For quantification of the percentage of cells producing a given
marker, in any given experiment the number of positive cells of
the whole well surface was determined relative to the total
number of DAPI-labeled nuclei. In a typical experiment, a total
of 500–1,000 cells were counted per marker. Statistical com-
parisons were made by Dunnett’s t test. If data were not nor-
mally distributed, a non-parametric test (Mann-Whitney U test)
was used for comparisons of results. All data are expressed as
mean  SEM.
RESULTS
Isolation and In Vitro Characterization of
Neurosphere-Forming Cells from the
Adult Tegmentum
To isolate tNSCs, the tegmentum (midbrain and hindbrain) was
selectively dissected from adult C57BL/6 mice using a dissec-
tion microscope. Cells were isolated and cultured in uncoated
flasks in serum-free NBa medium supplemented with EGF and
FGF-2. After 10–20 days in vitro, the cells formed small
spheres with all typical morphological properties of neuro-
spheres (Fig. 1A). FACS analysis revealed that the phenotype of
the tNSCs was CD24low/, CD34, CD45, Prominin1, and
SSEA1 (Fig. 1B). Furthermore, we used quantitative real-time
RT-PCR and immunocytochemistry on unfixed or fixed neuro-
spheres to investigate the expression pattern of several early and
late neuroectodermal genes (Fig. 2A, 2C; for complete names of
genes and encoded proteins, refer to Table 2). tNSCs expressed
high levels of early neuroectodermal markers such as Nestin, an
Table 2. (Continued)
Gene (protein) Sequence (forward; reverse)
Product length
(bp)
Melting point
analysis
a
NTRK1 5-GAG TTG AGA AGC CTA ACC ATC-3 104
(Neurotrophic tyrosine kinase,
receptor, type 1)
5-GCA TTG GAG GAC AGA TTC AGG-3
NR4A2 5-TGT CAG CAC TAC GGT GTT CG-3 2,263
(Nuclear receptor Nurr1) 5-AGG GTA AAC GAC CTC TCC G-3
Olig2 5-GAC CGA GCC AAC ACC AGC-3 166
(Oligodendrocyte transcription
factor 2; Olig2)
5-GGG ACG ATG GGC GAC TAG-3
Pax6 5-GCA CCA AAG GGT CAT CGC-3 193
(Paired box protein PAX6) 5-TGG GGG GTG GAT GGA AG-3
PLP 5-CAC CTA TGC CCT GAC TGT TG-3 176
(Myelin proteolipid protein) 5-GTG GAA GGT CAT TTG GAA CAT A-3
TH 5-AGC TCC TGC ACT CCC TGT C-3 175
(Tyrosine hydroxylase) 5-CGA GAG GCA TAG TTC CTG AGC-3
a
The x-axis represents temperature (from 68°C–92°C in 4°C steps), and the y-axis indicates fluorescence -d(F1)dT.
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Figure 1. Characteristics of adult tNSCs during in vitro expansion. (A): Morphology and marker expression of adult tNSCs during expansion in the
presence of EGF and FGF-2. Spheres were cultured for 2–3 hours to allow attachment and then stained for Nestin (b, i), Ki67 (d), Olig2 (e, i),
Neurogenin2 (f, j), NeuroD1 (g, k), and/or Musashi1 (h, l). For BrdU staining (c), the spheres were cultured in the presence of 10 M BrdU for 30
hours before plating. Nuclei were counterstained with DAPI. Confocal images (i–l) confirm the presence of the respective marker protein in nearly
all cells within the neurosphere. Arrows mark Ki67/DAPI cells (d) and apoptotic cells not expressing Nestin/Olig2 (e), respectively. Scale bars 
15 m (d), 30 m (e, i, j–l), 50 m (b, c, f–h), and 200 m (a). (B): Flow cytometry of tNSCs cultured for 4–12 weeks (five to 10 passages). Cells
were labeled with fluorescence-coupled antibodies against CD24, CD34, CD45, prominin1, and SSEA1 or immunoglobulin isotype control antibodies.
Cells were analyzed using a FACSCalibur flow cytometer. Black line, control immunoglobulin; red line, specific antibody. (C): Quantitative
transcription profile of tNSCs. Top panel: Representative real-time RT-PCR analysis using the LightCycler technique. Plot of the fluorescence versus
the cycle number obtained from SYBR Green detection of serially diluted NES mRNA (encoding for nestin). The crossing line represents the position
of the threshold. Diagram on right shows the standard curve obtained by plotting cycle number of crossing points versus dilution factor. Bottom panel:
Quantitative real-time RT-PCR analyses of NSC markers (NES, MSl1), proneural genes (NeuroD1, Neurog2, Olig2), and the neuronal transcription
factor Pax6 in tNSCs during expansion. Expression levels are expressed relative to the housekeeping gene HMBS. Data shown are mean values 
SEM from at least three independent experiments. For primers, complete names of genes, and melting curve analyses demonstrating the specificity
of amplified PCR products, see Table 2. Abbreviations: BrdU, 5-bromo-2-deoxyuridine; DAPI, 4,6-diamidino-2-phenylindole; EGF, epidermal
growth factor; FGF, fibroblast growth factor; HMBS, hydroxymethylbilane synthase; PCR, polymerase chain reaction; RT-PCR, reverse transcrip-
tion–polymerase chain reaction; tNSC, tegmental neural stem cell.
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intermediate filament protein present in CNS stem cells (Fig.
1A, 1C) [21, 41], and the CNS stem cell marker Musashi1 [42],
as well as the proneural genes Olig2, Neurogenin2, and Neu-
roD1 on both the mRNA and protein levels (Fig. 1A, 1C).
Proneural genes, which encode transcription factors of the basic
helix-loop-helix class, are important factors for NSC self-re-
newal, multipotency, and commitment to neural lineages of
NSCs [43–48]. Confocal microscopy of the spheres revealed
that nearly all (	95%) living cells without nuclear condensation
(DAPI stain) expressed Nestin (Fig. 1A) with some cells (
5%)
being double-positive for Nestin and GFAP (data not shown).
Co-labeling with anti-olig2 antibody further demonstrated co-
expression of both early neuroectodermal markers in nearly all
living cells (Fig. 1A). Furthermore, the proneural genes Neuro-
genin2 and NeuroD1, as well as the NSC marker Musashi1,
were expressed in nearly all cells within the neurospheres as
shown by confocal microscopy (Fig. 1A). The neurogenic fate-
determining transcription factor Pax6 mRNA was also ex-
pressed in these neurospheres (Fig. 1C). Only very few cells
were weakly positive for CD24 or PSA-NCAM protein (data not
shown). Markers for mature neural cell types, such as MBP,
PLP, NTRK1, MAP2, and TH, were undetectable or very low at
the mRNA level; at the protein level, MAP2ab, GalC, and TH
were absent (data not shown). This phenotype is similar to that
of NSCs derived from adult mouse SVZ or hippocampus [20,
22, 23]. tNSCs could be passaged and cultured as secondary and
tertiary neurospheres without changing morphology and pheno-
type for 3–12 weeks (5–10 passages).
Cell Cycle Distribution, Proliferation Potential, and
Apoptosis of tNSCs
Cell cycle analysis using PI-FACS demonstrated that, besides
apoptosis (see below), there was a large fraction of tNSCs
distributed in G1, S, and G2/M phases (see Fig. 2A, 2B for
details of cell cycle distribution). In addition, we used the
proliferation marker Ki67 as well as BrdU incorporation to
identify DNA-synthesizing cells (Figs. 1A and 2B). Ki67 was
detected in the nucleus of proliferating cells in all active phases
of the cell cycle from the late G1-phase through the M-phase but
is absent in non-proliferating and early G1-phase cells and in cells
undergoing DNA repair [49–51]. As expected, total Ki67 staining
(representing late G1 through M phase) was higher than total BrdU
staining at each time point. When the percentage of G1-phase cells
was subtracted from total Ki67 staining, the resulting percentage
was very similar to that of BrdU-stained cells (Fig. 2B).
To evaluate cell death by apoptosis during cultivation of
tNSCs, we used PI-FACS analysis and DAPI staining. After
4–12 weeks, an average number of 4%  1% of cells were
found by PI-FACS analyses to be apoptotic. Histograms repre-
senting FACS analysis and DAPI staining of apoptotic events in
tNSCs are shown in Figure 2B. Spontaneously apoptotic cells
exhibited chromatin condensation and margination, sometimes
followed by appearance of apoptotic bodies, as revealed by
DAPI staining, and were negative for Ki67 (data not shown) as
well as for most other markers tested such as Nestin and Olig2
(Fig. 1A).
Telomerase is inactive in most somatic cells but present
in various stem cell populations [52–54]. Quantification of
telomerase activity in tNSCs using the telomeric repeat am-
plification protocol [34, 35] showed stable telomerase activ-
ity in tNSCs over the 3-month expansion period with signif-
icantly higher activity compared to that measured in mouse
cortical tissue (negative control) but lower activity compared
to that in mouse ESCs (Fig. 2C). Together, investigations of
the proliferation characteristics revealed the typical pattern of
slowly dividing cells with a small amount of spontaneous
apoptosis within the tNSC neurospheres, similar to fetal
mouse mesencephalic NSCs [55].
Differentiation Capacity of Adult tNSCs
Differentiation of tNSCs was initiated after 3–12 weeks by
removal of mitogens, plating the cells onto poly-L-lysine, and
addition of BDNF, db-cAMP, and retinoic acid (protocol 1, Fig.
1A). After 14 days, the majority of cells (71%  27%) acquired
morphologic and phenotypic characteristics of astrocytes
(GFAP), 6%  5% acquired those of oligodendrocytes
(GalC), and 5%  2% those of mature neurons (MAP2ab;
n  8; Fig. 3B). GFAP, GalC, and Tuj1/MAP2ab were never
found in the same cell (Figs. 1D and 4A). Consistently, quan-
titative RT-PCR of tNSCs after differentiation using protocol 1
for 14 days confirmed the differentiation of tNSCs into mature
neuroectodermal cells (Fig. 3E). The NSC marker gene NES
Figure 2. Cell cycle distribution, proliferation potential, and apoptosis of adult tNSCs. (A): PI-FACS analysis of tNSCs showing the cell cycle
distribution typical for slowly dividing cells. (B): Quantitative data of PI-FACS analyses, Ki67 immunostaining, BrdU staining, and nuclei with
chromatin clumping and fragmentations (apoptotic nuclei) in DAPI stainings. (See Fig. 2A for Ki67, BrdU, and DAPI stainings of
neurospheres.) Results are the mean  SEM from three to six independent experiments. (C): Telomerase activity in tNSCs after 3 and 12 weeks,
respectively, as well as adult cortical tissue and mouse ESCs during expansion measured by the quantitative real-time telomeric repeat
amplification protocol. Telomerase activity was normalized to protein content. Results are mean values  SEM from three independent
experiments. #p 
 .05, ##p 
 .001 when compared with adult cortical tissue; p 
 .001 when compared with ESCs. Abbreviations: BrdU,
5-bromo-2-deoxyuridine; DAPI, 4,6-diamidino-2-phenylindole; ESC, embryonic stem cell; PI-FACS, propidium iodide–fluorescence-activated
cell sorting; tNSC, tegmental neural stem cell.
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(encoding Nestin) was downregulated sixfold, whereas mRNA
levels of NTRK1, GFAP, MBP, PLP, and NF increased six- to
430-fold during the differentiation process (Fig. 3E). Most
mRNA levels of markers for mature neural cell types in differ-
entiated tNSCs were lower compared with those in adult mouse
cortex (Fig. 3E). No dopaminergic or serotoninergic cells could
be detected using protocol 1. Replacement of BDNF/db-cAMP/
retinoic acid by various combinations of growth factors/cyto-
kines known to induce the dopaminergic phenotype in several
murine stem cell types [38] led to changes in the differentiation
Figure 3. In vitro differentiation capacity of tNSCs. (A): Schematic diagrams of protocols for differentiation of tNSCs (see Materials and Methods
for details). (B): tNSCs differentiated using protocol 1 were stained against markers for astrocytes (GFAP), oligodendrocytes (GalC), or neurons
(MAP2ab). Nuclei are counterstained with DAPI (blue). Scale bar  30 m. Quantification of differentiation capacity of 14-day cultures of tNSCs
differentiated using protocol 1. Data shown are mean values  SEM from eight independent experiments. (C): Immunocytochemical analysis of
differentiated tNSCs expanded for only 7 days. Prior to differentiation, tNSCs were incubated with 10 M BrdU for 30 hours and then differentiated
using protocol 1 and double-stained against GFAP or Tuj1 (green) and BrdU (red). Arrows indicate double-labeled cells. Scale bar  15 m. (D):
Clonal analysis of single tNSCs. Left panel: Secondary neurospheres can be derived from a single tNSC from expanded neurospheres. Scale bar 
200 m. Right panel: Differentiation capacity of clonally derived neurosphere cells. Progeny of single cell–derived neurospheres can be differentiated
into neurons (MAP2ab) and astrocytes (GFAP). Nuclei were counterstained with DAPI (blue). Scale bar  30 m. (E): Quantitative transcription
profile of tNSCs, differentiated tNSCs using protocol 1, and primary mouse cortical tissue. Results of quantitative real-time RT-PCR analyses of the
NSC marker gene Nestin (NES), the neural gene NTRK1, glial genes (GFAP, MBP, PLP), and the neuronal gene NF are displayed. Expression levels
are expressed relative to the housekeeping gene HMBS. For primers, complete names of genes, and melting curve analyses demonstrating the
specificity of amplified PCR products as listed in Table 2. Results are mean values  SEM from at least three independent experiments. #p 
 .05
when compared with tNSCs; p 
 .05 when compared with differentiated tNSCs. Abbreviations: BrdU, 5-bromo-2-deoxyuridine; DAPI, 4,6-
diamidino-2-phenylindole; DM, differentiation medium; DM-N2, differentiation medium supplemented with N2; FGF, fibroblast growth factor; GalC,
galactocerebrosidase C; GF, growth factor; GFAP, glial fibrillary acidic protein; MAP2ab, microtubule-associated protein 2ab; MEF, mouse
embryonic fibroblast; NBa, neurobasal medium; NF, neurofilament; NSC, neural stem cell; PLL, poly-L-lysin; RT-PCR, reverse transcription–
polymerase chain reaction; Shh, sonic hedgehog; tNSC, tegmental neural stem cell.
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capacity into astroglial, oligodendroglial, and neuronal cells, but
no TH neurons were observed (Table 1). For analyzing the
differentiation capacity of acutely isolated tNSCs before neuro-
sphere formation (7 days after preparation), we used the BrdU
incorporation assay. The tNSCs were incubated during the ex-
pansion phase with BrdU (10 M) for 30 hours. Then, differ-
entiation was initiated using protocol 1. We were able to detect
BrdU/Tuj1 neurons and BrdU/GFAP glial cells (Fig. 3C),
demonstrating that these neurons and glial cells were de novo–
generated from proliferating progenitor cells.
Next, we tested various multistep protocols with pre-stimu-
lation using FGF-8 and/or Shh for 48 hours in expansion me-
dium before plating the cells on PLL or feeder layers of several
cell types, including astroglia, MEFs, and PA6 stromal cells
(protocols 2–4; Fig. 3A). In fact, protocol 4 is similar to the
protocol for dopaminergic differentiation of mouse ESCs re-
ported by Kawasaki and coworkers [30]. There were no relevant
differences in the differentiation capacity of tNSCs into astro-
glia and neurons with respect to the various differentiation
conditions (Table 1). In contrast, only protocol 4 was able to
induce dopaminergic neurogenesis in a small percentage of cells
(2.4%  1.4% of Tuj1 cells; n  3), showing typical mor-
phological features of Tuj1/TH dopaminergic neurons with
small irregularly shaped soma and bipolar or multipolar branch-
ing processes with varicosities (Fig. 4A, 4B). Using quantitative
RT-PCR, we consistently demonstrated expression of various
dopaminergic marker genes, including NR4A2 (encoding the
nuclear receptor Nurr1), TH (TH), DDC (dopa-decarboxylase),
and DAT (dopamine transporter), in tNSCs differentiated using
protocol 4 (Fig. 4C). No dopaminergic neurogenesis could be
observed in cultures without PA6 cells (including protocols
using PA6 conditioned media), and there were no differences in
the amounts of glutamatergic, GABAergic, cholinergic, and
serotoninergic neurons in cultures with PA6 cells compared
with PA6 cell–free cultures (Fig. 4B; Table 1). Remarkably, the
morphology of the different nerve cell subtypes was signifi-
cantly different with large soma and multiple neurites in cho-
linergic cells and relatively small soma with two to three neu-
rites in GABAergic and glutamatergic neurons as described for
primary cultures (Fig. 4A). In contrast, protocol 4 also induced
glutamatergic, GABAergic, and cholinergic neurons out of cor-
responding adult mouse hippocampal NSCs but was unable to
produce TH dopaminergic cells out of hippocampal NSCs
(data not shown).
Clonal Analysis of Adult tNSCs
To determine whether individual tNSCs could generate both
neurons and glia, neurospheres were dissociated and individual
cells were isolated by the single-cell culture technique in ultra
low–attachment multiwell-plates. Single cells were cultured in
expansion medium for 3–6 weeks. One third of the single cells
proliferated to generate secondary neurospheres (Fig. 3D).
Clonal cells were then differentiated for 14 days using differ-
entiation protocol 1. Double immunostaining revealed that each
of these clonally derived neurospheres differentiated into neu-
rons and astrocytes (Fig. 3D). In addition to the BrdU incorpo-
ration experiments (Fig. 3C), these results demonstrate that
neurons and glia are de novo–generated from proliferating
tNSCs.
Functional Properties of Differentiated Adult tNSCs
To analyze the functional properties of differentiated tNSCs, we
performed whole-cell voltage-clamp recordings to measure volt-
age-gated sodium and potassium currents and current-clamp
recordings to measure the capacity to generate action potentials
Figure 4. Neuronal subtype differentiation capacity of tNSCs in vitro
established by using differentiation protocols 2–4 after an expansion
phase of 3–12 weeks. (A): Triple immunostaining of tNSCs differenti-
ated using protocol 4 for markers of astroglia (GFAP), neurons (Tuj1),
and oligodendroglia (GalC), as well as cholinergic (ChAT), GABAergic
(GABA), glutamatergic (glutamate), and dopaminergic (TH) neurons.
Nuclei were counterstained with DAPI (blue). Arrows mark double-
stained neurons. The inset shows high-magnification confocal image of
a Tuj1/TH neuron. Scale bars  30 m (left panel) or 15 m. (B):
Quantitative data of triple immunostainings of tNSCs differentiated with
protocols 2–4, respectively. Results are mean values  SEM from at
least three independent experiments. (C): Quantitative real-time RT-
PCR analyses of the dopaminergic marker genes nuclear receptor Nurr1
(NR4A2), TH (TH), dopa-decarboxylase (DDC), and dopamine trans-
porter (DAT) on tNSCs differentiated using protocol 4 (closed bars) and
negative control (open bars). Expression levels are expressed relative to
the housekeeping gene HMBS. For primers, complete names of genes,
and melting curve analyses, see Table 2. Results are mean values 
SEM from at least three independent experiments. ##p 
 .01 when
compared with negative control (PA6 cells alone). Abbreviations:
ChAT, cholineacetyltransferase; DAPI, 4,6-diamidino-2-phenylindole;
DAT, dopamine transporter; DDC, dopa-decarboxylase; GABA, -ami-
nobutyric acid; GalC, galactocerebrosidase C; GFAP, glial fibrillary
acidic protein; HMBS, hydroxymethylbilane synthase; RT-PCR, reverse
transcription–polymerase chain reaction; TH, tyrosine hydroxylase;
tNSC, tegmental neural stem cell.
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after differentiation for 10–20 days using protocol 1. The RMP
of differentiated tNSCs was 46  4 mV (n  34), the input
resistance was 536  45 M (n  48), and the cell membrane
capacity was 14.7  1.3 pF (n  48). Of differentiated tNSCs,
83 out of 95 recorded cells (87.4%) expressed a sustained
outward current of a few hundred pA up to 5 nA (Fig. 5A).
These currents showed a voltage dependence and kinetics char-
acteristic for A-type currents as well as tetraethylammonium-
sensitive delayed rectifier potassium channels (Fig. 5A, 5B). In
67 out of 95 cells (70.5%), we could identify inward currents of
up to 2 nA with voltage dependence and kinetics typical for
voltage-activated sodium channels (Fig. 5C, 5D). These currents
were tetrodotoxin (TTX)-sensitive (Fig. 5C). Current-clamp re-
cordings revealed that differentiated tNSCs generated TTX-
sensitive APs with a duration of 9.6  0.2 ms (n  8) and a
short AHP (Fig. 5E). The length of AHPs was 22.7  0.8 ms,
and the maximal amplitude 9.8  0.4 mV (n  8).
To further characterize the functional properties of differ-
entiated tNSCs, we measured the response of tNSCs differenti-
ated for 7 days using protocol 1 to various concentrations of
GABA (10–1,000 M), glutamate (1–300 M), or N-methyl-
D-aspartate (NMDA; 100 M). GABA elicited inward currents
in a dose-dependent manner with a half-maximal effective con-
centration (EC50 value) of 42 M (Fig. 6A, 6B). These currents
could be antagonized by co-application of bicuculline and en-
hanced by co-application of diazepam (Fig. 6C). The character-
istics of GABA-induced currents in our cells are typical for
GABAA receptors. Furthermore, glutamate induced fast inward
currents in a dose-dependent manner with an EC50 value of 8
M (Fig. 6D, 6E). Nine out of 10 cells expressing glutamate-
induced currents also showed functional NMDA receptors with
amplitudes of approximately 27% of the mean glutamate am-
plitude (Fig. 6F). Because there is no reliable evidence for
functional glutamate receptors of the NMDA subtype in glial
cells [56], these data further demonstrate functional properties
of mature nerve cells.
Neurotransmitter (dopamine and GABA) production and
release were studied on tNSCs differentiated using protocol 4.
Figure 5. Electrophysiological properties of adult tegmental NSCs differentiated using protocol 1 for 10 days. For voltage-clamp measurements
(A–D), cells were held at 70 mV and depolarized to 50 mV with increasing amplitudes in steps of 10 mV. (A): Representative traces from a
differentiated tNSC displaying inward and sustained outward currents. Potassium outward currents were markedly reduced by application of TEA (30
mM). (B): Current-voltage (I-V) relationships of the outward currents in steady state at the end of the voltage steps in the absence (f) and presence
of 30 mM TEA (). Data are mean values  SEM from three to 11 independent experiments. (C–D): Fast inward currents could be completely
blocked by application of TTX (1 M) and displayed the characteristic I-V relationship of voltage-gated sodium channels (n 7). (E): Current-clamp
recordings of the same cell recorded in (C) in response to depolarizing current pulses of increasing amplitude. The resting membrane potential was
approximately 65 mV, and TTX-sensitive action potentials peaked at approximately 40 mV. Abbreviations: TEA, tetraethylammonium; tNSC,
tegmental neural stem cell; TTX, tetrodotoxin.
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HPLC electrochemical detector analysis showed significant
amounts of dopamine in media conditioned by differentiated
tNSCs for 2 days (38.3  10.7 pg/ml; n  4; Fig. 7A, 7B), but
only small amounts of dopamine were found in extracellular
buffer or after stimulation of the cells with 56 mM KCl for 45
minutes. (Fig. 7B), consistent with the amounts of TH cells
and the expression of various dopaminergic marker genes,
including the key enzymes of dopamine synthesis (TH and
dopa-decarboxylase; Fig. 4). Under the same conditions, we
detected GABA production and potassium-dependent release
of GABA by differentiated tNSCs (Fig. 7B). There was no
dopamine production by undifferentiated tNSCs or tNSCs
differentiated using protocol 1. Consistent with the immuno-
cytochemical data, we did not find the neurotransmitter se-
rotonin in any sample.
DISCUSSION
Here, we provide evidence for the existence of multipotent
NSCs in the adult mouse tegmentum (midbrain and hindbrain
region) with the capacity to differentiate in vitro into functional
Figure 6. Electrophysiological properties of ligand-gated ion channels in adult tegmental neural stem cell (tNSCs) after in vitro differentiation for
7 days using differentiation protocol 1. The holding potential was 70 mV in whole-cell voltage-clamp mode, and substances were applied with a
rapid perfusion system every 30 seconds. (A): Representative recordings of GABA-induced inward currents after applications of increasing
concentrations of GABA (10–1,000 M). (B): GABA dose-response curve with an half-maximal effective concentration (EC50) value  41.5  1.1
M. Data are mean values  SEM from five independent experiments. (C): GABA-induced currents could be antagonized by co-application of
bicuculline and enhanced by co-application of diazepam. (D): Representative recordings of glutamate-induced inward currents after applications of
increasing concentrations of glutamate (1–300 M). (E): Glutamate dose-response curve with an EC50 value 8.2 1.8 M. Data are mean values
SEM from eight independent experiments. (F): NMDA-induced currents could be elicited in nine out of 10 cells expressing glutamate-induced
currents (mean NMDA amplitude was 27% of mean glutamate amplitude). Abbreviations: GABA, -aminobutyric acid; NMDA, N-methyl-D-
aspartate.
Figure 7. Neurotransmitter (dopamine, GABA) production and release of tNSCs differentiated on PA6 cells using protocol 4. (A): Representative
chromatograms of HPLC-ECD determination of dopamine in medium conditioned for 2 days by tNSCs on PA6 cells (protocol 4, red) and PA6 cells
alone (blue). Standard is presented in green. (B): Quantification of dopamine and GABA production in medium conditioned for 2 days (blue bars),
in extracellular buffer conditioned for 45 minutes (red bars), and in extracellular buffer  56 mM KCl conditioned for 45 minutes (green bars).
Abbreviations: DOPAC, dihydroxyphenyl acetic acid; GABA, -aminobutyric acid; HPLC-ECD, high-performance liquid chromatography–electro-
chemical detector; KCl, potassium chloride; tNSC, tegmental neural stem cell.
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nerve cell types, including dopaminergic neurons. We isolated
and cultured NSCs from the adult tegmentum (tNSCs) of
C57BL/6 mice using the neurosphere culture technique similar
to those used for isolation and propagation of fetal mesence-
phalic NSCs [29, 38, 57, 58]. Their phenotype was similar to
that of NSCs derived from adult mouse hippocampus, mouse
SVZ, or human fetal brain samples [20, 31, 59]. The tNSCs
were clonogenic, self-renewing cells that maintain the capacity
to differentiate into mature functional nerve cells, including
dopaminergic neurons (Figs. 3–7). Their potential to proliferate
was slower compared with embryonic/fetal NSCs, whereas their
differentiation capacity was similar to that of NSCs derived
from fetal rodent or human mesencephalon [29, 38, 55, 57, 58,
60].
NSCs are often defined in vitro by the presence of the CNS
stem cells marker Nestin [41, 61, 62], a class IV intermediate
filament protein [61, 63, 64] and a marker for precursor cells in
the adult brain [24, 61, 65–67]. Nestin is highly expressed in
tNSCs during in vitro expansion. Furthermore, the RNA-bind-
ing protein Musashi1 is involved in post-transcriptional gene
regulation in neuroprogenitors and/or NSCs and is used as a
marker of those cell types [42]. Consistently, Musashi1 is ex-
pressed in tNSCs both at the mRNA and protein levels (Fig. 1).
A large body of knowledge exists on lineage determination in
NSCs, because unlike many types of stem cells, NSCs undergo
self-renewal and multilineage differentiation in culture. Proneu-
ral genes, encoding transcription factors of the basic helix-loop-
helix class, such as NeuroD1, Neurogenin2, and Olig2, are both
necessary and sufficient to initiate the development of neural
lineages and to promote the generation of progenitors that are
committed to neural differentiation [43–45]. Proneural genes
are therefore expressed mostly in neuroprogenitor cells, includ-
ing NSCs in early neuroectodermal tissues [23, 46–48]. Con-
sistently, tNSCs expressed mRNA and protein of NeuroD1,
Neurogenin2, as well as Olig2 (Fig. 1). For example, NeuroD1
and Neurogenin2 are considered neuronal differentiation genes
and promote exit from the cell cycle and inhibit gliogenesis
[68–70]. In addition, Olig2 is a pivotal factor for neurogenesis
and oligodendroglial specification of adult NSCs in vitro [23,
71]. Although Olig2 showed no co-localization with adult CNS
stem cell markers in vivo, it becomes highly upregulated under
expansion conditions with high levels of EGF and FGF-2 (Fig.
1 and [23]). Olig2 is required for the proliferation and self-
renewal of neurosphere cells, as shown by interference analysis
[23]. The transcription factor Pax6 is the major neurogenic
determinant for radial glial cells and adult NSCs [23, 72–74].
Indeed, neurogenic differentiation in neurospheres fully depends
on the expression of the transcription factor Pax6, independent
of the region of origin [23]. Analysis of Pax6 expression in
tNSCs demonstrated Pax6 expression during the expansion
phase, further confirming their neurogenic potential (Fig. 2C).
Together, tNSCs expressed a typical pattern of early neuroec-
todermal and/or NSC marker genes during the expansion phase
in vitro, including major factors for proliferation and self-re-
newal as well as neurogenic differentiation, such as proneural
genes and Pax6.
Further evidence for the stem cell–like nature of tNSCs
within the neurospheres is the demonstration of clonogenicity of
individual cells in the single-cell culture assay showing the
potential of clonally derived neurospheres to differentiate into
both neurons and astrocytes. In addition, these results demon-
strate that neurons and glia are de novo–generated from prolif-
erating cells (Fig. 3C, 3D). Finally, showing proliferation by
PI-FACS analysis, BrdU labeling and Ki67 immunostaining as
well as the expression of telomerase [54], these tNSCs fulfill the
major characteristics of multipotent NSCs. After removal of
mitogens, plating the cells onto PLL, and incubation with
BDNF, db-cAMP, and retinoic acid for 14 days, tNSCs differ-
entiate into all major cell types of the CNS, namely mature
(MAP2ab) neurons, oligodendrocytes, and astrocytes with an
approximate ratio of 1:1.5:14, respectively. Replacement of the
mentioned growth factors with various combinations of growth
factors and/or cytokines did not lead to major changes of this
differentiation capacity (Table 1). In the presence of selected
growth factors (see Materials and Methods for details), tNSCs
differentiated into cells expressing the markers for cholinergic,
GABAergic, or glutamatergic neurons with similar amounts of
the distinct neuronal subpopulations with respect to the various
differentiation protocols. Thus, differentiation of tNSCs into
these neuronal subtypes did not depend on pre-stimulation with
FGF-8 and Shh or co-culture with feeder cells such as MEFs,
astrocytes, or PA6 cells (Fig. 4B). Interestingly, no serotonin-
ergic cells could be observed with any differentiation protocol
tested.
We further demonstrated that a high percentage of differen-
tiated adult tNSCs acquired functional properties of nerve cells,
such as generation of TTX-sensitive sodium channels and action
potentials similar to differentiated fetal mouse mesencephalic
NSCs [38] or adult NSCs derived from mouse SVZ [75]. A
subset of these cells expressed currents with the characteristics
of functional GABAA receptors as well as ionotropic glutamate
receptors, including the NMDA-subtype known to be expressed
exclusively by neuronal cells [56]. Together, this in vitro dif-
ferentiation capacity of tNSCs is similar to that of NSCs derived
from fetal brain as well as the principal neurogenic regions
(hippocampus and SVZ of the lateral ventricles) of the adult
brain of various species [21, 31, 41, 76–78]. Zhao and col-
leagues demonstrated neurogenesis in the adult substantia nigra
of C57BL/6 mice in vivo [7]. Two other studies did not find
newly born neurons in the adult substantia nigra of normal or
lesioned rodents [13, 16]. Moreover, Lie and colleagues found
the production of glial cells, but not of neuronal cells, from adult
substantia nigra progenitor cells in vivo [16]. In contrast, the in
vitro differentiation capacity of these substantia nigra NSCs
seems to include neuronal cell lineages [16]. However, this
study reported only differentiation into immature neurons
(NeuN or Tuj1 cells) and did not show any functionality or
neuron subtype specification [16].
The analysis of neuronal subtype differentiation of tNSCs
revealed that without pre-stimulating the cells with FGF-8 and
Shh and subsequent co-culture with PA6 stromal cells, no TH
dopaminergic neurons could be achieved. However, after a
multistep differentiation protocol using pre-stimulation and sub-
sequent co-culture of tNSCs with PA6 cells, a small subset of
cells not only acquired typical morphological features of dopa-
minergic cells but also produced the neurotransmitter dopamine,
demonstrating the differentiation of tNSCs into functional do-
paminergic neurons (Figs. 4, 7). No dopaminergic neurogenesis
was detected using other cell types for feeder layer cultures,
such as cortical or striatal astrocytes known to induce neuro-
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genesis in adult NSCs [78] or MEFs, normally used for prolif-
eration of ESCs. These data suggest a crucial role of PA6 cells
(or the so-called stromal cell–derived inducing activity [30]) on
dopaminergic neurogenesis not only for ESCs but also for adult
tNSCs. However, in contrast to ESCs, tNSCs seem to need an
additional priming step to become dopaminergic, such as the
pre-incubation procedure with FGF-8 and Shh used in the
present study.
Zhao and colleagues demonstrated dopaminergic neurogen-
esis in the adult substantia nigra of C57BL/6 mice in vivo [7].
A subsequent study was not able to reproduce these results or
demonstrate newly generated dopaminergic neurons by the
BrdU incorporation assay in normal or 6-hydroxydopamine–
lesioned animals [13]. In contrast to the latter results established
in vivo, we were able to show dopaminergic specification of
isolated adult tNSCs in vitro. This fact is in contrast to previous
results on adult NSCs not reporting dopaminergic specification
of adult NSCs in vitro independent of the region of origin of the
NSCs [7, 13, 16, 78]. The reasons for these discrepancies are
likely the following: (a) The in vivo differentiation capacity may
not reflect the entire lineage potential of resident progenitor
cells, because regional environmental factors appear to restrict
in situ differentiation to distinct neural lineages [16–18]. We
established a multistep differentiation protocol including co-
culturing the tNSCs with PA6 stromal cells known to have
potent effects on dopaminergic differentiation of ESCs in vitro
[30] to provide an environment sufficient for dopaminergic
specification in vitro of isolated and long-term expanded adult
tNSCs. However, the amounts of dopaminergic neurons gener-
ated from adult tNSCs are very low (2.5% of all neurons or
0.25% of all cells, which is five- to 10-fold less than differ-
entiated fetal mesencephalic NSCs derived from rodents or
humans) [29, 38, 79]. The knowledge of the specific factors
produced by PA6 stromal cells, which induce dopaminergic
specification, will help to further optimize the efficiency of
dopaminergic specification of adult NSCs. High yields of do-
paminergic cells would be essential for characterization of the
intracellular mechanisms of adult dopaminergic neurogenesis as
well as the NSC-derived dopaminergic neurons. (b) We used,
for the first time, NSCs from the whole adult tegmentum and not
just from the substantia nigra or the principal neurogenic regions
of the adult brain [7, 16, 78]. Future studies are warranted to
further define the exact region within the adult tegmentum from
which “pre-dopaminergic” NSCs can be generated.
SUMMARY
We demonstrated the presence of multipotent clonogenic NSCs
in the tegmentum of adult mice with the differentiation capacity
similar to embryonic/fetal mesencephalic NSCs, including spec-
ification into functional nerve cells such as dopaminergic and
GABAergic neurons. Previous reports suggest that these cells
were derived from the SVZ of the aqueduct and/or fourth
ventricle, a structure that is nearby the substantia nigra pars
compacta (A9 region) where the degenerating dopaminergic
neurons in Parkinson’s disease (PD) are located. Recent studies
failed to conclusively demonstrate dopaminergic neurogenesis
in the adult mammalian midbrain in vivo [7, 13, 16, 80], but our
results suggest that NSCs residing in the adult midbrain/hind-
brain area can give rise to new functional (dopaminergic) neu-
rons when exposed to appropriate environmental signals. The
presented developmental potential of adult tNSCs is one pre-
requisite for potential future endogenous cell replacement strat-
egies in PD. However, future studies are warranted to clarify the
mechanisms for controlling proliferation and dopaminergic dif-
ferentiation of these adult tNSCs. The presented novel cell
culture system provides a powerful tool for investigating these
molecular mechanisms of adult neurogenesis and dopaminergic
differentiation.
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